Advancing novel therapies to address genetically-validated cardioendocrine disease targets.
Investors 3
Mentions in press and media 2
| Date | Title | Description |
| 19.06.2024 | Marea Therapeutics Raises $190M in Funding | Marea Therapeutics, a San Francisco, CA-based clinical-stage biotechnology company incubated by Third Rock Ventures, raised $190M in combined Series A and B financings.
The Series A round was led by Third Rock Ventures and the Series B roun... |
| - | Marea Therapeutics | “The Next Frontier of Medicines for Cardiometabolic Diseases” |
Reviews 0
